Literature DB >> 25409101

Detection of upper airway status and respiratory events by a current generation positive airway pressure device.

Qing Yun Li1,2, Richard B Berry3, Mark G Goetting4, Bethany Staley2, Haideliza Soto-Calderon2, Sheila C Tsai5, Jeffrey G Jasko6, Allan I Pack2, Samuel T Kuna2,7.   

Abstract

STUDY
OBJECTIVES: To compare a positive airway pressure (PAP) device's detection of respiratory events and airway status during device-detected apneas with events scored on simultaneous polysomnography (PSG).
DESIGN: Prospective PSGs of patients with sleep apnea using a new-generation PAP device. SETTINGS: Four clinical and academic sleep centers. PATIENTS: Forty-five patients with obstructive sleep apnea (OSA) and complex sleep apnea (Comp SA) performed a PSG on PAP levels adjusted to induce respiratory events.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: PAP device data identifying the type of respiratory event and whether the airway during a device-detected apnea was open or obstructed were compared to time-synced, manually scored respiratory events on simultaneous PSG recording. Intraclass correlation coefficients between device-detected and PSG scored events were 0.854 for apnea-hypopnea index (AHI), 0.783 for apnea index, 0.252 for hypopnea index, and 0.098 for respiratory event-related arousals index. At a device AHI (AHIFlow) of 10 events/h, area under the receiver operating characteristic curve was 0.98, with sensitivity 0.92 and specificity 0.84. AHIFlow tended to overestimate AHI on PSG at values less than 10 events/h. The device detected that the airway was obstructed in 87.4% of manually scored obstructive apneas. Of the device-detected apneas with clear airway, a minority (15.8%) were manually scored as obstructive apneas.
CONCLUSIONS: A device-detected apnea-hypopnea index (AHIFlow) < 10 events/h on a positive airway pressure device is strong evidence of good treatment efficacy. Device-detected airway status agrees closely with the presumed airway status during polysomnography scored events, but should not be equated with a specific type of respiratory event.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  central sleep apnea; obstructive sleep apnea; positive airway pressure; respiratory event related arousal; upper airway

Mesh:

Year:  2015        PMID: 25409101      PMCID: PMC4355899          DOI: 10.5665/sleep.4578

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  13 in total

1.  An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults.

Authors:  Richard J Schwab; Safwan M Badr; Lawrence J Epstein; Peter C Gay; David Gozal; Malcolm Kohler; Patrick Lévy; Atul Malhotra; Barbara A Phillips; Ilene M Rosen; Kingman P Strohl; Patrick J Strollo; Edward M Weaver; Terri E Weaver
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

Review 2.  The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses.

Authors:  R Nisha Aurora; Susmita Chowdhuri; Kannan Ramar; Sabin R Bista; Kenneth R Casey; Carin I Lamm; David A Kristo; Jorge M Mallea; James A Rowley; Rochelle S Zak; Sharon L Tracy
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

Review 3.  Recognition and management of complex sleep-disordered breathing.

Authors:  Geoffrey S Gilmartin; Robert W Daly; Robert J Thomas
Journal:  Curr Opin Pulm Med       Date:  2005-11       Impact factor: 3.155

4.  Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure.

Authors:  Marcel A Baltzan; Ibrahim Kassissia; Osama Elkholi; Mark Palayew; Richard Dabrusin; Norman Wolkove
Journal:  Sleep       Date:  2006-04       Impact factor: 5.849

5.  Evaluation of the apnea-hypopnea index determined by the S8 auto-CPAP, a continuous positive airway pressure device, in patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Kanako Ueno; Takatoshi Kasai; Gregory Brewer; Hisashi Takaya; Ken-ichi Maeno; Satoshi Kasagi; Fusae Kawana; Sugao Ishiwata; Koji Narui
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

6.  Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry.

Authors:  Stephen D Pittman; Giora Pillar; Richard B Berry; Atul Malhotra; Mary M MacDonald; David P White
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

7.  Pharyngeal narrowing/occlusion during central sleep apnea.

Authors:  M S Badr; F Toiber; J B Skatrud; J Dempsey
Journal:  J Appl Physiol (1985)       Date:  1995-05

8.  Accuracy of autotitrating CPAP to estimate the residual Apnea-Hypopnea Index in patients with obstructive sleep apnea on treatment with autotitrating CPAP.

Authors:  Himanshu Desai; Anil Patel; Pinal Patel; Brydon J B Grant; M Jeffery Mador
Journal:  Sleep Breath       Date:  2009-05-01       Impact factor: 2.816

9.  Accuracy of an intelligent CPAP machine with in-built diagnostic abilities in detecting apnoeas: a comparison with polysomnography.

Authors:  M Gugger; J Mathis; C Bassetti
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

10.  Comparison of polysomnography with ResCare Autoset in the diagnosis of the sleep apnoea/hypopnoea syndrome.

Authors:  P A Bradley; I L Mortimore; N J Douglas
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

View more
  9 in total

1.  The Respiratory Signature: A Novel Concept to Leverage Continuous Positive Airway Pressure Therapy as an Early Warning System for Exacerbations of Common Diseases such as Heart Failure.

Authors:  Christopher N Schmickl; Eric Heckman; Robert L Owens; Robert J Thomas
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

2.  Sudden Improvement in PAP Download Indices Without Treatment Change.

Authors:  Susheela Hadigal; Surina Sharma; Mary H Wagner; Scott Ryals; Richard B Berry
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

3.  Diagnostic Accuracy and Clinical Utility of Overnight Pulse Oximetry.

Authors:  Mirna Ayache; Kingman P Strohl
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

4.  Confusing Signals During a Positive Airway Pressure Titration.

Authors:  Richard B Berry; Scott Ryals; Mary H Wagner
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

5.  Validation of the System One RemStar Auto A-Flex for Obstructive Sleep Apnea Treatment and Detection of Residual Apnea-Hypopnea Index: A European Randomized Trial.

Authors:  Frédéric Gagnadoux; Dirk Pevernagie; Poul Jennum; Nina Lon; Corinne Loiodice; Renaud Tamisier; Petra van Mierlo; Wojciech Trzepizur; Martina Neddermann; Annika Machleit; Jeffrey Jasko; Jean Louis Pépin
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

Review 6.  APAP, BPAP, CPAP, and New Modes of Positive Airway Pressure Therapy.

Authors:  Karin G Johnson
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

7.  Electronic health record-derived outcomes in obstructive sleep apnea managed with positive airway pressure tracking systems.

Authors:  Brian W Locke; Sarah E Neill; Heather E Howe; Michael C Crotty; Jaewhan Kim; Krishna M Sundar
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

8.  Cheyne-Stokes Breathing as a Predictive Indicator of Heart Failure in Patients With Obstructive Sleep Apnea; A Retrospective Case Control Study Using Continuous Positive Airway Pressure Remote Monitoring Data.

Authors:  Kimimasa Saito; Yoko Takamatsu
Journal:  Front Cardiovasc Med       Date:  2022-02-07

Review 9.  Telemonitoring for the Follow-Up of Obstructive Sleep Apnea Patients Treated with CPAP: Accuracy and Impact on Therapy.

Authors:  Cécile Dusart; Stéphanie Andre; Thomas Mettay; Marie Bruyneel
Journal:  Sensors (Basel)       Date:  2022-04-05       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.